// App-Quantinova.ai

1025 : A prolyl-hydroxylase inhibitor, ethyl-3,4-dihydroxybenzoate, induces cell autophagy and apoptosis in esophageal squamous cell carcinoma cells

Researchers

Presenter

  • Wei Li

Principal Investigators

  • Guixue Hou

  • Dianrong Zhou

  • Xiaomin Lou

  • Yang Xu

  • Siqi Liu

  • Xiaohang Zhao

Medical Centers

  • Cancer Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, China

  • CAS Key Laboratory of Genome Sciences and Information, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, China

  • Graduate School of Southern Medical University, Guangzhou, China

  • Cancer Hospital Chinese Academy of Medical Sciences, Beijing, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Esophageal squamous carcinoma cell

  • Esophageal Cancer

  • Solid malignancies

Biomarkers

  • N-Myc downregulated gene 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved